Evidence map›Paper›PMID 9343439›Full record

ArticleMolecular and cellular biology1997

Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation.

J L Cheshire, A S Baldwin

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 178 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J L CheshireLineberger Comprehensive Cancer Center, Department of Biology and Curriculum in Genetics and Molecular Biology, University of North Carolina School of Medicine, Chapel Hill 27599, USA.
A S Baldwin
UNC Lineberger Comprehensive Cancer Center

Funding

Unexpected Nucleosomal Functions for the IKKsR37AI035098 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BALDWIN, ALBERT SIDNEY · 2004 to 2013
$3.2M
TNF SIGNALING--ACTIVATION OF NF-KB AND GENE EXPRESSIONR01AI035098 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI BALDWIN, ALBERT SIDNEY · 1994 to 2003
$981k
NF KB AND THE DEVELOPMENT OF ALZHEIMERS DISEASEF32AG005745 · NIA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CHESHIRE, JEANETTE L · 1996 to 1997
–
NIAID NIH HHS AI35098NIA NIH HHS 1 F32 AG05745-01
6 · The paper itself

Abstract

Tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma) are required for an effective immune response to bacterial infection and these cytokines synergize in a variety of biological responses, including the induction of cytokine, cell adhesion, and inducible nitrous oxide synthase gene expression. Typically, the synergistic effect on gene expression is due to the independent activation of nuclear factor kappaB (NF-kappaB) by TNF-alpha and of signal transducers and activators of transcription or IFN-regulatory factor 1 by IFNs, allowing these transcription factors to bind their unique promoter sites. However, since activation of NF-kappaB by TNF-alpha is often transient and would not activate long-term kappaB-dependent transcription effectively, we explored the effects of IFN-gamma on TNF-alpha-induced NF-kappaB activity. IFN-gamma, which typically does not activate NF-kappaB, synergistically enhanced TNF-alpha-induced NF-kappaB nuclear translocation via a mechanism that involves the induced degradation of I kappaBbeta and that apparently requires tyrosine kinase activity in preneuronal cells but not in endothelial cells. Correspondingly, cotreatment of cells with TNF-alpha and IFN-gamma leads to persistent activation of NF-kappaB and to potent activation of kappaB-dependent gene expression, which may explain, at least in part, the synergy observed between these cytokines, as well as their involvement in the generation of an effective immune response.

Indexed as

I-kappa B ProteinsAnimalsBiological TransportCell CompartmentationCell NucleusDNA-Binding ProteinsDrug SynergismEndothelium, VascularGene Expression RegulationGenisteinInterferon-gammaModels, BiologicalNF-kappa BNF-KappaB Inhibitor alphaPC12 CellsRatsDNA-Binding ProteinsGenisteinI kappa B beta proteinI-kappa B ProteinsInterferon-gammaNF-kappa BNF-KappaB Inhibitor alphaNfkbia protein, ratTumor Necrosis Factor-alpha

Identifiers

PMID9343439
PMCPMC232529
OpenAlexW2101574511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.